Status:
COMPLETED
Evaluation of the Safety and Usability of the M3T Fertigo System and Its Calibration
Lead Sponsor:
Instituto Valenciano de Infertilidad, IVI VALENCIA
Conditions:
Infertility, Female
Eligibility:
FEMALE
18-40 years
Brief Summary
We have developed a new minimally invasive system for endometrial dating, that allows the physician to monitor, capture, project and analyze the actual morphology and maturity of the endometrial surfa...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Healthy women
- Age: 18 - 40, both inclusive
- Regular menstrual cycles
- Exclusion criteria:
- Simultaneous participation in another clinical study that, at researcher's criteria, could interfere with the results of this study
- Current pregnancy
- Women with known existing endometrial pathology
- Women with known oligo-ovulation or un-ovulation.
- Women who were diagnosed with Endometriosis or Adenomyosis
- Women with medical history of malignant tumors in their reproductive system
- Women with IUD in place
- Women menstruating on the day of the procedure
- Women who have signs and symptoms of PID
- Women who currently use any hormonal medications.
Exclusion
Key Trial Info
Start Date :
September 14 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 26 2023
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT05440019
Start Date
September 14 2022
End Date
April 26 2023
Last Update
October 24 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ivi Valencia
Valencia, Spain, 46015